Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,981.00
Bid: 1,985.00
Ask: 1,987.00
Change: 8.00 (0.41%)
Spread: 2.00 (0.101%)
Open: 1,967.00
High: 1,989.00
Low: 1,966.00
Prev. Close: 1,973.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 11th Mar 2014 09:03

Aviva: RBC Capital takes target price from 400p to 550p upgrading to neutral. Nomura increases target price from 489p to 625p and reiterates a buy recommendation.Balfour Beatty: Citi raises target price from 220p to 310p maintaining a neutral rating. Goldman Sachs reduces target price from 335p to 291p and leaves its neutral rating unchanged.BBA Aviation: Liberum Capital moves target price from 290p to 305p, but still recommends selling.Berendsen: JP Morgan increases target price from 1089p to 1127p and stays with its overweight rating.Capita Group: Cantor Fitzgerald raises target price from 1200p to 1300p retaining a buy recommendation.Centrica: Berenberg cuts target price from 380p to 365p, while upgrading to buy.Clarkson: JP Morgan raises target price from 2050p to 2370p upgrading to overweight.Computacenter: Credit Suisse moves target price from 734p to 744p and retains an outperform rating.Costain Group: Liberum Capital upgrades to buy with a target price of 300p.Fenner: FinnCap increases target price from 322p to 430p and maintains its outperform rating. Investec lowers target price from 380p to 375p and retains its sell recommendation.Gem Diamonds: Goldman Sachs downgrades to neutral with a target price of 185p.Genel Energy: Bank of America ups target price from 1225p to 1250p and leaves its buy recommendation unchanged.Goals Soccer Centres: Canaccord Genuity takes target price from 220p to 280p and keeps a buy recommendation.G4S: Deutsche Bank lowers target price from 225p to 221p and retains a hold recommendation.Hikma Pharmaceuticals: Citi increases target price from 1260p to 1700p reiterating a buy recommendation.International Consolidated Airlines Group: Jefferies raises target price from 410p to 510p and retains a buy recommendation.Interserve: Liberum Capital ups target price from 620p to 650p upgrading to buy.Johnson Matthey: Liberum Capital reduces target price from 3500p to 3340p downgrading to hold.Kier Group: Liberum Capital raises target price from 1800p to 1915p, while downgrading to hold.Lonmin: Goldman Sachs takes target price from 290p to 330p and upgrades to neutral.National Grid: Berenberg ups target price from 740p to 785p and keeps a hold recommendation.Next: Bank of America increases target price from 7000p to 7400p maintaining a buy recommendation.Old Mutual: Goldman Sachs shifts target price from 220p to 224p and retains a buy recommendation.Reckitt Benckiser: Bank of America increases target price from 5250p to 5600p and reiterates a buy recommendation.Reed Elsevier: Investec ups target price from 950p to 1000p and keeps a buy recommendation.Rightmove: Credit Suisse raises target price from 2700p to 3100p and retains its outperform rating.Royal Bank of Scotland: Nomura moves target price from 285p to 300p and maintains a reduce rating.Schroders: Numis raises target price from 2736p to 2982p and stays with its add rating.Spirent Communications: Jefferies shifts target price from 103p to 108p and keeps a hold recommendation.SSE: Berenberg reduces target price from 1570p to 1320p and retains a hold recommendation.Staffline Recruitment: Liberum Capital upgrades to buy with a target price of 630p.Trinity Exploration Production: Investec initiates with a target price of 250p and a buy recommendation.Tyman: Canaccord Genuity ups target price from 325p to 350p and maintains a buy recommendation.
More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.